Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiuwei Zhuhuang San (JWZHS) is a traditional Tibetan multi-herb formulation (patent medicine) included in the Chinese Ministry of Health drug standards for Tibetan medicine (Volume 1). The prescription is composed of nine natural ingredients: Tianzhuhuang (Bambusae Concretio Silicea), Niuhuang (Calculus Bovis), Honghua (Carthami Flos), Ligadu (Meconopsis), Gancao (Glycyrrhizae Radix et Rhizoma), Congfu (Inula), Tuercao (Lagotis), Tanxiang (Santalum album), and Bangga (Aconitum). Its therapeutic actions are described as clearing heat, inducing detoxification, reducing phlegm, and relieving cough. It is primarily indicated for the treatment of upper respiratory tract infections (URTI), associated cough, and pneumonia, particularly in pediatric patients aged 2 to 14 years.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jiuwei zhuhuang san.